Mesoblast Ltd (OTC Pink - Current Information:MBLTY)

14.50
Delayed Data
As of Apr 24
 +0.44 / +3.13%
Today’s Change
12.34
Today|||52-Week Range
27.01
-18.36%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$927.2M

Company Description

Mesoblast Ltd. engages in the development of bio-therapeutics based on its proprietary cell-based and protein technologies. Its proprietary cell-based core technologies include highly purified, immunoselected Mesenchymal Precursor Cells (MPCs), culture-expanded Mesenchymal Stem Cells (MSCs), Dental Pulp Stem Cells (DPSCs), and expanded Hematopoietic Stem Cells (HSCs). Its protein technologies are based on factors derived from its proprietary cellular platforms, including Stromal Derived Factor-1 (SDF-1). The company was founded by Itescu Silviu on June 8, 2004 and is headquartered in Melbourne, Australia.

Contact Information

Mesoblast Ltd.
Level 38
Melbourne Victoria (vic) 3000
P:(139) 639-6036
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Silviu ItescuChief Executive Officer, Executive Director & MD
Paul HodgkinsonChief Financial Officer
Donna L. SkerrettChief Medical Officer
Suzanne LipeVice President-Operations
Susan Elizabeth MacLemanHead-Commercialization

To view my watchlist

Not a member yet?

Sign up now for a free account